Vertex lays off 125 workers after type 1 diabetes cell therapy failed study in Marchnews2025-06-11T01:06:41+00:00June 11th, 2025|Endpoints News|
Makary looks at ways to speed FDA approvals, talks about cutting user feesnews2025-06-05T18:38:48+00:00June 5th, 2025|Endpoints News|
Trump health appointees pledge support for cell and gene therapies at FDAnews2025-06-05T17:54:23+00:00June 5th, 2025|Endpoints News|
Regenxbio reports Duchenne gene therapy data from five patientsnews2025-06-05T14:35:07+00:00June 5th, 2025|Endpoints News|
Sarepta’s gene therapy vector wins FDA platform technology statusnews2025-06-04T19:49:13+00:00June 4th, 2025|Endpoints News|
#ASCO25: Brain cancer cell therapies make early stridesnews2025-06-03T10:00:45+00:00June 3rd, 2025|Endpoints News|
#ASCO25: Immatics reports more early-stage data for melanoma cell therapy with pivotal trial underwaynews2025-05-31T12:00:59+00:00May 31st, 2025|Endpoints News|
Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDAnews2025-05-27T11:24:26+00:00May 27th, 2025|Endpoints News|
CRISPR Therapeutics partners with siRNA company, showing that gene editing isn’t the only answernews2025-05-20T18:52:16+00:00May 20th, 2025|Endpoints News|
Retro Biosciences inks blood disorder deal as Sam Altman-backed biotech seeks $1B in fundsnews2025-05-20T04:01:33+00:00May 20th, 2025|Endpoints News|
